<mediadc-video-embed data-state="{"cms.site.owner":{"_ref":"00000161-3486-d333-a9e9-76c6fbf30000","_type":"00000161-3461-dd66-ab67-fd6b93390000"},"cms.content.publishDate":1662039651694,"cms.content.publishUser":{"_ref":"0000017d-fe9d-da96-ad7d-ffbf8a5c0000","_type":"00000161-3461-dd66-ab67-fd6b933a0007"},"cms.content.updateDate":1662039651694,"cms.content.updateUser":{"_ref":"0000017d-fe9d-da96-ad7d-ffbf8a5c0000","_type":"00000161-3461-dd66-ab67-fd6b933a0007"},"rawHtml":"
var _bp = _bp||[]; _bp.push({ "div": "Brid_61970409", "obj": {"id":"27789","width":"16","height":"9","video":"1087729"} }); ","_id":"00000182-f948-d446-af92-fdd969b10000","_type":"2f5a8339-a89a-3738-9cd2-3ddf0c8da574"}”>Video EmbedModerna and Pfizer-BioNTech’s updated COVID-19 booster vaccines that target the highly transmittable omicron variant are expected to be ready for administration in a matter of days after an advisory group for the Centers for Disease Control and Prevention signed off on the updated shots.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
Already a member? Log in
